Exagen Inc. Common Stock

XGNNASDAQ • USD
ThemeMedical Devices & HealthTech›Diagnostic Imaging & Equipment
7.27 USD
↘ 0.21 (2.81%)AT CLOSE (03:59 PM EDT)
7.31
↗ 0.04 (0.48%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
7.31
↗ 0.04 (0.48%)
🔴Market: CLOSED

XGN is currently priced at $7.27. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place XGN at a fair price relative to peers.

Technical & fundamental data as of Oct 23, 2026.

Open?$7.43
High?$7.46
Low?$7.17
Prev. Close?$7.48
Volume?222.8K
Avg. Volume?343.0K
VWAP?$7.27
Rel. Volume?0.65x
Bid / Ask
Bid?$7.15 × 100
Ask?$9.09 × 100
Spread?$1.94
Midpoint?$8.12
Valuation & Ratios
Market Cap?176.1M
Shares Out?24.2M
Float?17.3M
Float %?71.3%
P/E Ratio?N/A
P/B Ratio?14.42
EPS?-$0.78
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
Themes
Medical Devices & HealthTech›Diagnostic Imaging & EquipmentHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
220
Market Cap
176.1M
Industry
SERVICES-MEDICAL LABORATORIES
Website
www.exagen.com
Listed
2019-09-19
Address
1261 LIBERTY WAY
VISTA, CA 92081
Phone: (760) 560-1501
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
91
Short Sent.?
60
Piotroski F-Score?2/9Weak
Altman Z-Score?-13.52Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.08%Low
Short Interest?704.6K
Days to Cover?2.5
Free Float17.3M
Avg Daily Volume286.4K
Settlement Date2026-09-30
Financial Health
Current Ratio?3.18Strong
Quick Ratio?3.18Strong
Cash Ratio?1.83Strong
Debt/Equity?2.09High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
13
14.42HIGH▾
P/S?
Peers
100
S&P
58
2.48CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-16.4CHEAP▾
EV/Sales?
Peers
100
S&P
68
2.49CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-154.9%WEAK▾
ROA?
S&P
3
-36.4%WEAK▾
Cash Flow & Enterprise
FCF?$-7588000
Enterprise Value?$177.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist